
Impact of metabolic syndrome on short-term outcome of carotid revascularization: a large sample size study in Chinese population
Author(s) -
Xuesong Bai,
Yao Feng,
Tao Wang,
Zhou Xiao,
Changlin Yang,
Ya-Bing Wang,
Hua Yang,
Jie Lu,
Feiqi Zhu,
Yanfei Chen,
Peng Gao,
Renjie Yang,
Yan Ma,
Liqun Jiao
Publication year - 2020
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001038
Subject(s) - medicine , mace , carotid endarterectomy , metabolic syndrome , univariate analysis , cardiology , diabetes mellitus , surgery , carotid arteries , percutaneous coronary intervention , multivariate analysis , myocardial infarction , obesity , endocrinology
Metabolic syndrome (MetS) is relatively common worldwide and an important risk factor for cardiovascular diseases. It is closely linked to arterial stiffness of the carotid artery. However, the association of MetS with the safety of carotid revascularization has been rarely studied. The aim of this study was to observe the current status of MetS and its components in Chinese carotid revascularized patients, and investigate the impact on major adverse clinical events (MACEs) after carotid endarterectomy (CEA) or carotid artery stenting (CAS).